LKB1 mutations seem to be more frequent in poorly differentiated adenocarcinomas than in well-differentiated tumors, and mouse models indicate that LKB1 deficiency alone do not cause lung tumors, however synergize with other mutations. This evidence concerns the gene STK11 and adenocarcinoma.